Holder snapshot 7 signals
Share change
+10,299,160
Put/Call ratio
115%
SEC-reported price per share
$47.82
Number of holders
236
Value change
+$498,492,380
Number of buys
133
Open additional details 1 more signal available
Number of sells
96
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,559,344

Security key

90400D108

Report period

Q4 2023

Institutions

236

Top holders

10

Ownership snapshot

Top reported holders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock, $0.001 par value (the "Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $257,862,440 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $257.86M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $257.86M
RTW INVESTMENTS, LP $192.69M
WELLINGTON MANAGEMENT GROUP LLP $185.23M
BlackRock Finance, Inc. $181.07M
PRICE T ROWE ASSOCIATES INC /MD/ $112.66M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$257,862,440
7,233,168 shares
— 30 Sep 2023
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$192,691,423
5,405,089 shares
— 30 Sep 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$185,233,121
5,195,880 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$181,073,802
5,079,209 shares
— 30 Sep 2023
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$112,661,000
3,160,160 shares
— 30 Sep 2023
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$91,877,786
2,577,217 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
236
Shares
80,397,353
Rows available
236
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
219
Q4 2023 holders
236
Holder diff
17
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .